The BATTLE trial: a bold step toward improving the efficiency of biomarker-based drug development
- PMID: 22586314
- DOI: 10.1158/2159-8274.CD-11-0036
The BATTLE trial: a bold step toward improving the efficiency of biomarker-based drug development
Abstract
Successful completion of the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial, reported in this issue of Cancer Discovery, is an important advance in the effort to improve clinical trial approaches to the simultaneous development of new therapeutics with matching diagnostic tests so that patients most likely to benefit from these therapies can be identified.
Comment on
-
The BATTLE trial: personalizing therapy for lung cancer.Cancer Discov. 2011 Jun;1(1):44-53. doi: 10.1158/2159-8274.CD-10-0010. Epub 2011 Jun 1. Cancer Discov. 2011. PMID: 22586319 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
